Literature DB >> 10674446

Is intensive follow-up really able to improve prognosis of patients with local recurrence after curative surgery for rectal cancer?

G B Secco1, R Fardelli, S Rovida, D Gianquinto, E Baldi, P Bonfante, L Derchi, R Ferraris.   

Abstract

BACKGROUND: Because more than 90% of local recurrences after curative surgery for rectal cancer appear within the first 36 months after surgery, an intensive and strict follow-up program during this period could improve early diagnosis and, thus, prognosis of patients.
METHODS: Of the 216 patients who underwent surgery for rectal cancer, 127 entered an intensive follow-up program (median follow-up: 42 months); the clinical outcome of the remaining 89 patients was reconstructed with the help of their general practitioners.
RESULTS: Fifty eight (26.8%) of the 216 patients who were treated with curative surgery alone developed a local recurrence; pelvic recurrences were prevalent. Eleven (30.5%) of the 36 patients who had recurrence during follow-up, and 6 of the 22 who had not undergone follow-up, had a reoperation with curative intent; the median survival was 19 months vs. 8 months, respectively (P = ns). Four (44.4%) curative reoperations were performed on the 9 asymptomatic patients and in 13 (26.5%) of the 49 cases with symptomatic local recurrences. Median survival was 15 months vs. 14 months, respectively (P = n.s). All patients except one (living after 42 months from reoperation) died within 48 months.
CONCLUSIONS: In our study, adherence to a strict follow-up program unfortunately proved to be ineffective for improving long-term survival for patients who underwent reoperation with curative intent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674446     DOI: 10.1007/s10434-000-0032-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  [Recurrent rectal cancer: diagnosis by contrast enhancement in MD-CT].

Authors:  C A Stückle
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

2.  [Improvements in detection of rectal cancer recurrence by multiplanar reconstruction].

Authors:  C A Stückle; K F Haegele; M Jendreck; R Kickuth; O Schneider; G Hohlbach; D Liermann
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

3.  Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer.

Authors:  Kenji Matsuda; Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Yoshimasa Oku; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2009-06-10       Impact factor: 3.445

4.  Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.

Authors:  Jian-Bin Hu; Xiao-Nan Sun; Qi-Chu Yang; Jing Xu; Qi Wang; Chao He
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

5.  Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.

Authors:  Luis C Fernandes; Su B Kim; Sarhan S Saad; Delcio Matos
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 6.  Colorectal cancer surveillance: what's new and what's next.

Authors:  Johnie Rose; Knut Magne Augestad; Gregory S Cooper
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Predictors of successful salvage surgery for local pelvic recurrence of rectosigmoid colon and rectal cancers.

Authors:  Akihiko Kobayashi; Masanori Sugito; Masaaki Ito; Norio Saito
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

8.  Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma.

Authors:  Thijs Wieldraaijer; Pascal Bruin; Laura A M Duineveld; Pieter J Tanis; Anke B Smits; Henk C P M van Weert; Jan Wind
Journal:  Dig Surg       Date:  2017-03-14       Impact factor: 2.588

9.  Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.

Authors:  Liviu V Titu; Anthony A Nicholson; John E Hartley; David J Breen; John R T Monson
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

Review 10.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.